Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice. [electronic resource]
Producer: 19990422Description: 7-15 p. digitalISSN:- 0031-1820
- Administration, Cutaneous
- Animals
- Antigens, CD -- blood
- Drug Carriers
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Infusion Pumps
- Liposomes
- Malaria, Cerebral -- parasitology
- Mice
- Mice, Inbred C57BL
- Parasitemia -- drug therapy
- Plasmodium berghei
- Receptors, Tumor Necrosis Factor -- blood
- Receptors, Tumor Necrosis Factor, Type II
- Recombinant Proteins -- therapeutic use
- Specific Pathogen-Free Organisms
- Time Factors
- Tumor Necrosis Factor-alpha -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.